Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

Study by Veranex and Proteomics International Demonstrates Clinical Utility of Prognostic Test for Type 2 Diabetes Patients

admin.veranex : Mar 24, 2025 10:23:07 PM

Commercialization

By conducting a clinical utility study for Proteomics International’s PromarkerD (a blood-based test that predicts the risk of kidney disease/decline in Type 2 diabetes patients), Veranex provided evidence of the test’s value to physicians and its ability to affect patient management.

View Article

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

admin.veranex : Mar 24, 2025 10:22:49 PM

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Commercialization
Read More

1 min read

Medicare Clarifies Confusion Over Tests Covered by the NGS NCD

Gary Keeler : Mar 24, 2025 10:23:13 PM

The Medicare NGS NCD grants national coverage for somatic testing in patients with advanced cancer if the test has FDA-approval or -clearance as a...

Read More

German Draft Executive Order Provides Clarity for Reimbursement of Health Apps

Gary Keeler : Mar 24, 2025 10:23:11 PM

Towards the end of 2019, the German Federal Parliament introduced a simplified process for approval and reimbursement of digital health apps...

Read More